University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program (PAH QuERI Ext)

This program intends to improve the management of pulmonary arterial hypertension (PAH) patients through an evidence-based approach aimed at achieving optimal World Health Organization (WHO) functional class (FC): 1. Improving FC III & IV patients to FC II, 2. Improving FC II patients to FC I, and 3. Maintaining FC II & FC I patients.


Please refer to identifier NCT01389206 for more information.

Start Date
June 1, 2011
End Date
March 31, 2016
Gender Preference
Age Group
18 - 99 years
Principal Investigator
Sif Hansdottir, MD
Contact Info

Pulmonary Hypertension Program

Cynthia Larew, RN

phone:  319-356-1028

fax:  319-356-7087


Heart ; High blood pressure in lungs ; PAH ; PH ; Pulmonary arterial hypertension ; Pulmonary diseases ; Pulmonary hypertension ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.